etoposide has been researched along with B-Cell Lymphoma in 204 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (13.24) | 18.2507 |
| 2000's | 106 (51.96) | 29.6817 |
| 2010's | 58 (28.43) | 24.3611 |
| 2020's | 13 (6.37) | 2.80 |
| Authors | Studies |
|---|---|
| Bednarski, PJ; Emmrich, T; Hirt, C; Kiefer, T; Leffler, U; Lemmerhirt, H; Link, A; Schulz, R; Sydow, K | 1 |
| Attarbaschi, A; Burkhardt, B; Ebinger, M; Garthe, AK; Kabíčková, E; Klapper, W; Knörr, F; Kühnle, I; Maecker-Kolhoff, B; Oschlies, I; Ruf, S; Simonitsch-Klupp, I; Woessmann, W; Zimmermann, M | 1 |
| Lakhotia, R; Melani, C; Roschewski, M; Wilson, WH | 1 |
| Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L | 1 |
| Hou, SL; Li, L; Lian, K; Zhang, QH | 1 |
| Angelopoulou, MK; Arapaki, M; Belia, M; Drandakis, I; Korkolopoulou, P; Lakiotaki, E; Panitsas, F; Plata, E; Siakantaris, MP; Triantafyllou, EF; Vassilakopoulos, TP | 1 |
| Benn, BS; Ivanick, NM; Moh, M; Seeley, EJ | 1 |
| Chen, X; Han, S; Lei, T; Li, C; Lu, F; Peng, S; Yang, H; Yu, H | 1 |
| Allione, B; Calimeri, T; Cattaneo, C; Donadoni, G; Facchetti, F; Ferrari, D; Ferreri, AJM; Foppoli, M; Fumagalli, L; Lleshi, A; Pecciarini, L; Ponzoni, M; Re, A; Rigacci, L; Rossi, G; Sassone, M; Spina, M; Verga, L | 1 |
| Kubal, TE; Li, W; McCarthy, KT; Richter, KA; Tobon, KA | 1 |
| Lei, MM; Lou, U; Roeland, E; Uchida, E | 1 |
| A Rouche, J; Abdayem, P; Danu, A; Dartigues, P; Desmaris, R; El Dakdouki, Y; Fermé, C; Ghez, D; Ibrahim, N; Lazarovici, J; Michot, JM; Ribrag, V; Rossignol, J; Willekens, C | 1 |
| Inoue, K; Kawamoto, K; Masuko, M; Mitobe, M; Miyoshi, H; Ohshima, K; Shibasaki, Y; Sone, H; Suwabe, T; Suzuki, T; Takizawa, J | 1 |
| Altmann, B; Bentz, M; Borchmann, P; Dreyling, M; Frontzek, F; Glass, B; Haenel, M; Held, G; Horn, H; Kroschinsky, FP; Lenz, G; Loeffler, M; Metzner, B; Nickelsen, M; Ott, G; Rosenwald, A; Schmitz, N; Staiger, AM; Truemper, L; Viardot, A; Ziepert, M | 1 |
| Aleshin, M; Borok, J; Sarantopoulos, G; Worswick, S | 1 |
| Amengual, JE; Barta, SK; Bast, MA; Behdad, A; Blum, KA; Calzada, O; Cassaday, RD; Chavez, JC; Cohen, JB; Costa, C; Falkiewicz, MK; Feldman, T; Fenske, TS; Gerson, JN; Hernandez-Ilizaliturri, F; Hill, BT; Howlett, C; Kaplan, JB; Landsburg, DJ; Lansigan, F; Li, S; Lue, JK; Maly, J; Mato, AR; Medeiros, LJ; Nathan, S; Olszewski, AJ; Peace, DJ; Persky, DO; Petrich, AM; Reddy, NM; Rivera, X; Singavi, A; Torka, P; Vose, JM | 1 |
| Hou, AJ; Jia, RF; Jiang, L; Yang, XY | 1 |
| Bocchia, M; Cencini, E; Fabbri, A; Gentili, F; Mazzei, MA; Schiattone, L | 1 |
| Calzada, O; Chavez, J; Cohen, JB; Costa, LJ; Epperla, N; Faruqi, F; Fenske, TS; Ganguly, S; Ghosh, N; Hamadani, M; Huntington, SF; Kanate, AS; Kharfan-Dabaja, MA; Kovach, AE; Obiozor, C; Okal, R; Reddy, N; Shah, NN; Strelec, L; Svoboda, J; Szabo, A; Vose, J; Xavier, AC | 1 |
| Fenske, TS; Hamadani, M; Shah, NN; Svoboda, J | 1 |
| Melani, C; Roschewski, M; Wilson, WH | 1 |
| Adams, T; Al-Kateb, H; Anwer, F; Fuchs, D; Johnstone, L; Lau, BM; McGhan, L; Shadoan, PK | 1 |
| Abou Yehia, Z; Akhtari, M; Armand, P; Chuang, HH; Dabaja, BS; Fanale, M; Fuller, CD; Gunther, JR; LaCasce, AS; Martin-Doyle, W; Mawlawi, O; Medeiros, LJ; Milgrom, SA; Nastoupil, L; Neelapu, S; Ng, AK; Oki, Y; Pinnix, CC; Qiao, W; Smith, GL; Westin, J; Wogan, CF | 1 |
| Dührsen, U; Lamm, W; Liebregts, T; Turki, AT | 1 |
| Sun, B; Wang, Y; Xu, X; Zhang, L; Zhang, Q; Zhang, Y | 1 |
| Czuczman, MS; Edvardsen, K; Fayad, L; Fecteau, D; Fennessy, M; Henkel, K; Jewell, RC; Joyce, R; Kharfan-Dabaja, MA; Liao, Q; Lisby, S; Lossos, IS; Matasar, MJ; Moskowitz, CH; Rodriguez, MA; Shea, TC; Singh, RP; Spitzer, G | 1 |
| Gisselbrecht, C | 1 |
| Hudson, MM; Kastan, MB; Kennedy, W; Onciu, M; Sandlund, JT | 1 |
| Auperin, A; Baruchel, A; Bergeron, C; Bertrand, Y; Coze, C; Lacombe, MJ; Lervat, C; Leverger, G; Méchinaud, F; Munzer, M; Nelken, B; Patte, C | 1 |
| Belada, D; Berková, A; Bolomská, I; Burešová, L; Campr, V; Klener, P; Kozák, T; Kubáčková, K; Matuška, M; Pirnos, J; Přibylová, J; Pytlík, R; Sýkorová, A; Trněný, M; Vášová, I | 1 |
| Ling, CC; Liu, XQ; Shao, Y | 1 |
| Camphausen, K; Dunleavy, K; Jaffe, ES; Nicolae, A; Pittaluga, S; Roschewski, M; Shovlin, M; Staudt, LM; Steinberg, SM; Wilson, WH | 1 |
| Anderson, JR; Barth, M; Cairo, MS; Frazer, JK; Galardy, P; Goldman, S; Gross, TG; Harrison, L; Perkins, SL; Sanger, W; Shiramizu, B; Smith, L; Weinstein, H | 1 |
| Ando, K; Kawada, H; Kobayashi, H; Miyamoto, M; Murayama, H; Ogawa, Y; Ohmachi, K; Onizuka, M; Sawanobori, M; Shirasugi, Y; Tazume, K; Toyosaki, M; Tsuboi, K; Tsuma-Kaneko, M; Wasada, I | 1 |
| Hasegawa, K; Hirayama, Y; Ishihara, T; Kanagawa, M; Koyama, J; Suzuki, T; Terui, T | 1 |
| Banat, A; Basara, N; Derigs, G; Flohr, T; Frickhofen, N; Gramatzki, M; Hess, G; Kirschey, S; Kolbe, K; Link, H; Meyer, RG; Peter, N; Schmitz, N; Schulz, A; Theobald, M; Weidmann, E; Wolf, HH | 1 |
| Fujimi, A; Hamaguchi, K; Hashimoto, A; Hayasaka, N; Iwasaki, S; Kamihara, Y; Kanisawa, Y; Kato, J; Matsumoto, T; Minami, S; Nakajima, C; Okuda, T; Shibata, T; Yamada, S | 1 |
| Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
| Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP | 1 |
| Yang, YZ | 1 |
| Bhattacharya, S; Maiti, A | 1 |
| Dunleavy, K; Fojo, T; Gharwan, H; Grant, C; Lai, C; Shovlin, M; Steinberg, SM; Wilson, WH | 1 |
| Chen, Z; Hu, S | 1 |
| Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
| Dul, C; Khan, U | 1 |
| Cortes, JE; Estrov, Z; Ferrajoli, A; Garcia-Manero, G; Jabbour, E; Kantarjian, HM; Khouri, M; Khoury, JD; Ko, H; O'Brien, SM; Pierce, S; Ravandi, F; Short, NJ; Thomas, DA; Thompson, PA; Verstovsek, S; Wierda, WG | 1 |
| Keller, U; Licht, T; Menzel, H; Müller, A; Peschel, C; Von Schilling, C | 1 |
| Kravchenko, SK; Kremenetskaia, AM; Lorie, IuIu; Obukhova, TN; Vorob'ev, IA; Vorob'ev, VI; Zvonkov, EE | 1 |
| Andresen, S; Bolwell, B; Chan, J; Copelan, E; Dean, R; Kalaycio, M; Koo, A; Pohlman, B; Rybicki, L; Sobecks, R; Sweetenham, J | 1 |
| Barnich, M; Cairo, M; Chang, M; Griffin, TC; Gross, TG; Hutchison, R; Shiramizu, B; Weinstein, H; Weitzman, S; Wiley, J; Woods, D | 1 |
| Chiocca, E; Mekhjian, HS; Peruzzi, P; Porcu, P; Ray-Chaudhuri, A; Slone, WH | 1 |
| Beaven, AW; Chao, N; Gabriel, DA; Garcia, RA; Gockerman, JP; Moore, DT; Rizzieri, DA; Serody, JS; Shea, TC | 1 |
| Choi, YH; Huh, J; Jang, G; Kang, BW; Kim, C; Kim, S; Kim, SW; Kim, WS; Lee, DH; Lee, JS; Lee, SS; Ryu, JS; Suh, C | 1 |
| Lerner, A; Rosen, JE; Soto, J | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Chadburn, A; Dezube, BJ; Henry, DH; Kaplan, LD; Lee, JY; Leichman, L; Levine, AM; Mitsuyasu, R; Noy, A; Ramos, JC; Ratner, L; Remick, SC; Shah, MH; Sparano, JA; Von Roenn, J; Wachsman, W | 1 |
| Baker, L; Cochrane, L; Delabie, J; Holte, H; Lauritzsen, GF; Mahendra, P; Roberts, C; Tauro, S | 1 |
| Asai, T; Hangaishi, A; Imai, T; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K; Yamamoto, G | 1 |
| Avilés, A; de Jesús Nambo, M; Huerta-Guzmán, J; Neri, N | 1 |
| Gill, D; Ho, AD; Kuhnt, E; Loeffler, M; Österborg, A; Pettengell, R; Pfreundschuh, M; Rieger, M; Walewski, J; White, D | 1 |
| Cory, S; Cragg, MS; Dewson, G; Haga, JM; Happo, L; Herold, MJ; Jansen, ES; Michalak, EM; Phipson, B; Scott, CL; Smyth, GK; Strasser, A; Vandenberg, CJ | 1 |
| Kato, J; Mori, T; Okamoto, S; Shimizu, T; Tsukada, Y; Ueda, T; Yokoyama, K | 1 |
| Ardeshna, KM; Goldstone, AH; Kayani, I; Linch, DC; Lowry, L; Marafioti, T; Mohamedbhai, SG; Sibson, K | 1 |
| Azuma, T; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Nomoto, J; Taniguchi, H; Tobinai, K; Watanabe, T | 1 |
| Chen, RL; Chuang, SS; Lu, YH | 1 |
| Glass, B; Griesinger, F; Hasenkamp, J; Hohloch, K; Lakhani, VJ; Meller, J; Riggert, J; Sahlmann, CO; Trümper, L; Wulf, G | 1 |
| Csomor, J; Deák, B; Gaudi, I; Lengyel, Z; Lovey, J; Matolcsy, A; Molnár, Z; Petri, K; Rosta, A; Schneider, T; Tóth, E; Várady, E | 1 |
| Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kiso, S; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kura, Y; Kurita, D; Miura, K; Sawada, U; Takei, K; Takeuchi, J; Tanaka, T; Yagi, M; Yamazaki, T | 1 |
| Bahlis, NJ; Carlson, L; Duan, Q; Duggan, P; Hasegawa, W; Russell, JA; Stewart, DA; Voralia, M | 1 |
| Cavallin-Stahl, E; Glass, B; Haenel, M; Kaiser, U; Loeffler, M; Pfreundschuh, M; Schmitz, N; Truemper, L; Wolf, M; Zeynalova, S | 1 |
| Bhattacharyya, J; Hoshi, M; Kimura, A; Mihara, K; Ohtsubo, M; Sakai, A; Takei, Y; Takihara, Y; Yanagihara, K; Yasunaga, S | 1 |
| de Rooij, M; Huijgens, PC; Visser, OJ; Wondergem, MJ; Zijlstra, JM; Zweegman, S | 1 |
| Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ | 1 |
| Fu, K; Hao, XS; Hou, Y; Li, LF; Li, W; Liu, XM; Qian, ZZ; Qiu, LH; Wang, HQ; Zhang, HL; Zhou, SY | 1 |
| Bentz, M; Borchmann, P; Doelken, G; Ehninger, G; Glass, B; Haenel, M; Loeffler, M; Nickelsen, M; Peter, N; Pfreundschuh, M; Rosenwald, A; Ruebe, C; Schmidt, C; Schmitz, N; Truemper, L; Viardot, A; Ziepert, M | 1 |
| Bénéteau, M; Carles, M; Chiche, J; Cornille, A; Jacquin, MA; Marchetti, S; Meynet, O; Pradelli, LA; Ricci, JE; Zunino, B | 1 |
| Herbrecht, R; Jarfaut, A; Levêque, D; Santucci, R | 1 |
| Fujii, H; Iwai, T; Nakagawa, H; Ueda, Y | 1 |
| Auroux, J; Bernardeau, M; Cavicchi, M; Delchier, JC; Haioun, C; Tsakiris, L | 1 |
| Pranesh, N | 1 |
| Chen, H; Chen, J; Fu, RY; Gu, LJ; Pan, C; Tang, JY; Wang, YP; Wu, Y; Xue, H; Zhao, H | 1 |
| Berkow, RL; Hilliard, LM; Watts, RG | 1 |
| Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
| Franchini, G; Grant, N; Gutierrez, M; Jaffe, ES; Kavlick, MF; Little, RF; Mitsuya, H; Pittaluga, S; Raffeld, M; Shearer, G; Steinberg, SM; Wilson, WH; Yarchoan, R | 1 |
| Hamlin, PA; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; Portlock, CS; Qin, J; Satagopan, JM; Straus, DJ; Verbel, D; Yahalom, J; Zelenetz, AD | 1 |
| Lauterbach, I; Mann, G; Niemeyer, C; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Seidemann, K; Simonitsch, I; Stankewitz, K; Tiemann, M; Zimmermann, M | 1 |
| Kadowaki, S; Kawakami, K; Watanabe, Y | 1 |
| Avigan, D; Giallombardo, N; Hurley, D; Joyce, RM; Lamontagne, D; Levine, J; McDermott, D; Ottaway, J; Regan, M; Smith, T; Tetreault, JC; Uhl, L; Umiel, T | 1 |
| Griniūte, R; Pileckyte, M | 1 |
| Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A | 1 |
| Fukuda, T; Kurosu, T; Miki, T; Miura, O | 1 |
| Boccadoro, M; Caracciolo, D; Cuttica, A; Dell'Aquila, M; Di Nicola, M; Gianni, AM; Ladetto, M; Magni, M; Marinone, C; Pileri, A; Rosace, M; Tarella, C; Zallio, F | 1 |
| Addicks, K; Lackner, K; Nuss, D | 1 |
| Ambrosetti, A; Cabras, MG; Di Vito, F; Fioritoni, G; Gabbas, A; Gallamini, A; Gallo, E; Gargantini, L; Gottin, L; Lazzarino, M; Menestrina, F; Morra, E; Orlandi, E; Palestro, M; Pasini, F; Paulli, M; Pizzolo, G; Pizzuti, M; Rossi, G; Secchi, S; Tarella, C; Tecchio, C; Todeschini, G; Vitolo, U | 1 |
| Filippa, DA; Gencarelli, A; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; O'Connor, O; Portlock, C; Qin, J; Straus, D; Teruya-Feldstein, J; Waxman, A; Yahalom, J; Zelenetz, AD | 1 |
| Blood, A; Bryson, G; Edwards, CJ; Gobe, GC; Ishii, HH; Pat, BK; Sculley, TB | 1 |
| Kitawaki, T; Nishikori, M; Ohno, H; Uchiyama, T; Ueda, C | 1 |
| Feller, AC; Glass, B; Hasenclever, D; Hossfeld, DK; Kloess, M; Loeffler, M; Metzner, B; Pfreundschuh, M; Reiser, M; Rübe, C; Rudolph, C; Schmits, R; Schmitz, N; Trümper, L | 1 |
| Betticher, DC; Egli, F; Honegger, HP; Jacky, E; Jermann, M; Jost, LM; Kroner, T; Stahel, RA; Taverna, Ch | 1 |
| Eimermacher, H; Feller, AC; Hasenclever, D; Hossfeld, DK; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rübe, C; Rudolph, C; Schmits, R; Schmitz, N; Trümper, L | 1 |
| Hoang-Xuan, K; Levy, V; Soussain, C | 1 |
| Aleksza, M; Gergely, L; Illés, A; Ponyi, A; Sipka, S; Szegedi, G; Váróczy, L | 1 |
| Blystad, AK; Delabie, J; Holte, H; Ikonomou, I; Kvalheim, G; Kvaløy, S; Vålerhaugen, H | 1 |
| Chen, XQ; Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Liu, DG; Su, YS; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM | 1 |
| Bertz, H; Fetscher, S; Finke, J; Lange, W; Waller, CF; Zeiser, R | 1 |
| Acquatella, G; Carneiro, M; García, R; Gómez, R; Hernández, M; Insausti, CL; Nouel, A; Santos, S | 1 |
| Berretta, M; Cattaneo, C; Jaeger, U; Michieli, M; Nigra, E; Rieger, AC; Rossi, G; Simonelli, C; Sparano, JA; Spina, M; Talamini, R; Tirelli, U; Vaccher, E | 1 |
| Cillessen, SA; Gundy, C; Jansen, PM; Jiwa, NM; Kluin-Nelemans, HC; Kummer, JA; Meijer, CJ; Muris, JJ; Ossenkoppele, GJ; Oudejans, JJ; van Houdt, IS; van Krieken, JH; Vos, W | 1 |
| Deák, B; Eid, H; Esik, O; Horváth, A; Horváth, GI; Keresztes, S; Lengyel, Z; Lovey, J; Molnár, Z; Rosta, A; Schneider, K; Schneider, T; Tóth, E; Várady, E | 1 |
| Carde, P; Ferme, C; Girinsky, T; Koscielny, S; Lapusan, S; Ribrag, V | 1 |
| Fadeel, B; Orrenius, S; Pervaiz, S; Sun, Y | 1 |
| Fukushima, T; Hirose, Y; Itoh, H; Karasawa, H; Kawabata, H; Kojima, Y; Masaki, Y; Ogawa, N; Sawaki, T; Shimoyama, K; Sugai, S; Sutoh, H; Wano, Y | 1 |
| Acholonu, S; Anderlini, P; Champlin, RE; Couriel, D; De Lima, M; Donato, ML; Fayad, L; Giralt, S; Hosing, C; Jones, R; Khouri, IF; Korbling, M; Maadani, F; Manning, JT; McLaughlin, P; Okoroji, GJ; Pro, B; Saliba, RM; Shpall, E; Younes, A | 1 |
| Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J | 1 |
| Bertrand, R; Droin, N; Parent, N; Sané, AT | 1 |
| Meijer, CJ; Muris, JJ; Oudejans, JJ | 1 |
| Nath, SV; Seymour, JF | 1 |
| Dietl, J; Djakovic, A; Ott, G; Vordermark, D; Zollner, U | 1 |
| Miyahara, S; Mizutani, M; Murabayashi, K; Ogawa, T; Yabana, T | 1 |
| Fukuda, T; Koyama, T; Kurosu, T; Miki, T; Miura, O; Takahashi, Y | 1 |
| Aversa, S; Billio, A; Brunori, M; Candela, M; Centurioni, R; Chisesi, T; Congiu, AM; Contu, A; Crugnola, M; De Souza, C; Majolino, I; Marino, G; Nati, S; Olivieri, A; Patti, C; Porcellini, A; Rubagotti, A; Santini, G; Sertoli, MR; Spriano, M; Tedeschi, L; Vimercati, R | 1 |
| Al-Rajhi, N; Connors, JM; Gascoyne, RD; Klasa, R; Paltiel, C; Savage, KJ; Voss, N | 1 |
| Beitler, B; Bellesso, M; Chamone, D; de Almeida Macedo, MC; Dias, LC; Dorlhiac-Llacer, PE; Dulley, FL; Neto, AE; Pereira, J; Pracchia, LF | 1 |
| Fan, Y; Huang, ZY; Luo, LH; Yu, HF | 1 |
| Aoyama, Y; Hagihara, K; Hino, M; Hirai, M; Hirose, A; Kanashima, H; Koh, KR; Kosaka, S; Kumura, T; Manabe, M; Mugitani, A; Nakajima, Y; Nakamae, M; Nakao, Y; Ohta, K; Sakamoto, C; Sakamoto, E; Terada, Y; Teshima, H; Yamane, T | 1 |
| Bentz, M; Berdel, WE; Feller, A; Glass, B; Kloess, M; Loeffler, M; Pfreundschuh, M; Schlimok, G; Schmitz, N; Trümper, L | 1 |
| Broglia, C; Corazza, GR; Federico, M; Gobbi, PG; Lambelet, P; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Polimeno, G; Riezzo, A; Rovati, A; Valentino, F | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Kobayashi, K; Oka, S; Tsuji, M; Yokote, T | 1 |
| Bohlius, J; Engert, A; Hülsewede, H; Kober, T | 1 |
| Kageyama, Y; Kihara, K; Kobayashi, T; Kubo, Y; Yokoyama, M | 1 |
| Benson, W; Bradstock, KF; Crombie, C; Gottlieb, D; Hertzberg, MS; Taper, J | 1 |
| Gisselbrecht, C; Hagberg, H | 1 |
| Adde, M; Enblad, G; Hagberg, H; Laurell, A; Sundström, C | 1 |
| Aurran, T; Biron, P; Bouabdallah, R; Boulat, O; Chabannon, C; Chetaille, B; Coso, D; Esterni, B; Gastaut, JA; Ivanov, V; Maraninchi, D; Rey, J; Schiano de Collela, JM; Sebban, C; Stoppa, AM; Xerri, L | 1 |
| Dabbas, B; Ford, CD; Gabor, F; Morgan, R | 1 |
| Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M | 1 |
| Beitler, B; Chamone, DA; Chaoubah, A; Dulley, FL; Hallack Neto, AE; Llacer, PD; Macedo, MC; Pereira, J | 1 |
| Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lu, TX; Xia, YF; Xian, CG; Zhang, YJ | 1 |
| Bo, LJ; Chen, YH; Jin, XP; Liang, AB; Liu, B; Wang, F | 1 |
| Leonard, JP; Siegel, AB | 1 |
| Baldini, L; Bertini, M; Botto, B; Cabras, G; Di Vito, F; Federico, M; Gallo, E; Liberati, AM; Luminari, S; Marcheselli, L; Merli, F; Mozzana, R; Naglieri, E; Orsucci, L; Pennese, E; Polimeno, G; Vitolo, U | 1 |
| Andresen, S; Bolwell, BJ; Brown, S; Dean, R; Hsi, ED; Kalaycio, M; Pohlman, B; Rybicki, LA; Smith, SD; Sobecks, R; Sweetenham, JW | 1 |
| Estella, J; Fernández-Delgado, R; Forns, M; Gallego, S; García-Miguel, P; Indiano, JM; Javier, G; Navajas, A; Pardo, N | 1 |
| Boccadoro, M; Bregni, M; Cabras, A; Calvi, R; Caracciolo, D; Comino, A; Corradini, P; Devizzi, L; Di Nicola, M; Fornari, A; Gallamini, A; Gianni, AM; Ladetto, M; Magni, M; Majolino, I; Mirto, S; Novero, D; Patti, C; Pescarollo, A; Ponzoni, M; Remotti, D; Rosato, R; Stella, M; Tarella, C; Zanni, M; Zoli, V | 1 |
| Ahn, HS; Chang, HM; Huh, J; Kang, HJ; Kang, YK; Kim, MJ; Kim, TW; Lee, H; Lee, JL; Lee, Y; Park, JH; Ryu, MH; Yoo, C | 1 |
| Ansell, SM; Colgan, JP; Habermann, TM; Inwards, DJ; Johnston, PB; Markovic, SN; Micallef, IN; Porrata, LF; Ristow, KM; Simpson, L; Witzig, TE | 1 |
| Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P | 1 |
| Saitou, K; Saitou, Y; Suzuki, S; Uzuka, Y; Yamaguchi, M | 1 |
| Chi, HS; Huh, J; Jang, S; Kim, MK; Kim, S; Kim, SW; Lee, DH; Lee, SS; Park, CJ; Suh, C; Sym, SJ | 1 |
| Carlson, N; Dal Cin, P; Deng, J; Letai, A; Shipp, M; Takeyama, K | 1 |
| Fibbe, WE; Huijgens, PC; Lugtenburg, PJ; van 't Veer, MB; van Imhoff, GW; van Oers, MH; van Putten, WL; Vellenga, E; Verdonck, LF; Wijermans, PW; Zijlstra, JM | 1 |
| Kagami, Y; Kato, H; Kikuchi, A; Morishima, Y; Ogura, M; Oki, Y; Oshiro, A; Taji, H; Tsujimura, A; Yamamoto, K | 1 |
| Kono, T; Noguchi, T; Nohara, J; Sakaguchi, Y; Terada, Y | 1 |
| Csomor, J; Egyed, M; Egyházi, Z; Fekete, S; Kaszás, I; Kollár, B; Pajor, L; Timár, B | 1 |
| Bar Ziv, J; Or, R; Polliack, A; Safadi, R | 1 |
| Hagiwara, Y; Hayakawa, T; Kanayama, T; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M | 1 |
| Hara, A; Kaku, Y; Nishimura, Y; Sakai, N; Yamada, H | 1 |
| Brugger, W; Engelhardt, R; Kanz, L; Mertelsmann, R | 1 |
| Crowther, D; Ghielmini, M; Morgenstern, GR; Pettengell, R; Radford, JA; Scheid, C; Stern, PL | 1 |
| Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
| Egami, K; Furusawa, S; Mikuni, C; Mori, M; Nomura, T; Shimoyama, M; Sugimoto, T; Suzuki, K; Takagi, T; Yoshida, T | 1 |
| Ashida, T; Ayabe, T; Maekawa, I; Namiki, M; Shibata, Y; Taruishi, M | 1 |
| Benczúr, M; Kopper, L; Mihalik, R | 1 |
| Bergmann, L; Hoelzer, D; Jäger, E; Karakas, T; Knuth, A; Mitrou, PS; Stutte, HJ; Weidmann, E | 1 |
| Hizawa, Y; Itoh, J; Kawamura, S; Munakata, A; Nakui, Y; Saitoh, S; Satoh, T; Taka-mi, H; Tamura, Y; Tsushima, K | 1 |
| Amin, K; Anderlini, P; Andersson, B; Cabanillas, F; Champlin, R; Claxton, D; de Lima, M; Donato, M; Gajewski, J; Giralt, S; Khouri, I; Mehra, R; Popat, U; Preti, A; Przepiork, D; Pugh, W; Rodriguez, A; Rodriguez, J; Romaguera, J; van Besien, K | 1 |
| Bloom, SE; Muscarella, DE; Rachlinski, MK; Sotiriadis, J | 1 |
| Bauer, PI; Kopper, L; Mihalik, R; Peták, I; Sebestyén, A; Süli-Vargha, H | 1 |
| Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Magrath, I; Neely, J; Nieder, M; Owen, W; Seibel, N; Shad, A; Venzon, D; Wilson, W | 1 |
| Cunningham, D; Popescu, RA; Wotherspoon, AC | 1 |
| Bloor, AJ; Marcus, RE; Seale, JR | 1 |
| Hoshino, T; Iwamoto, T; Kuroko, K; Nishida, S; Shirai, C | 1 |
| Hoffman, M; Lesser, M; Rai, K; Xu, JC | 1 |
| Bättig, B; Cerny, T; Cogliatti, SB; Fey, MF; Kappeler, A; Laissue, JA; Mueller-Garamvoelgyi, E; Schmid, U | 1 |
| Bauer, P; Kopper, L; Krajcsi, P; Kun, E; Marton, A; Mihalik, R; Peták, I | 1 |
| Meyn, RE; Story, MD | 1 |
| Dive, C; Hickman, JA; Taylor, ST | 1 |
| Buthmann, U; Freund, M; Kleine, HD; Volk, J | 1 |
| Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Mateo-Navarro, A; Rodilla Sala, E; Ruíz-Hernández, G; Solano-Vercet, C; Terol-Castera, MJ | 1 |
| Chizzali-Bonfadin, C; Filipits, M; Heinzl, H; Jaeger, U; Pirker, R; Simonitsch, I | 1 |
| Appelbaum, FR; Bernstein, ID; Borrow, JW; Bush, SA; Durack, LD; Eary, JF; Fisher, DR; Gooley, T; Gopal, AK; Liu, S; Maloney, DG; Martin, PJ; Matthews, DC; Petersdorf, S; Porter, B; Press, OW; Rajendran, JG; Smith, JP; Wood, B | 1 |
| Fujimori, Y; Itoh, T; Kakishita, E; Mori, A; Nishimura, Y; Okada, M; Okamoto, T; Saheki, K; Takatsuka, H; Tamura, A; Wada, H; Yamada, S | 1 |
| Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
| Beham-Schmid, C; Hoefler, G; Linkesch, W; Neumeister, P; Sill, H | 1 |
| Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
| Atra, A; Gerrard, M; Hann, IM; Hobson, R; Imeson, JD; Pinkerton, CR | 1 |
| Auperin, A; Behrendt, H; Coze, C; Frappaz, D; Leverger, G; Lutz, P; Michon, J; Patte, C; Perel, Y; Raphaël, M; Terrier-Lacombe, MJ | 1 |
| Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K | 1 |
| Avigan, D; Giallombardo, N; Hurley, D; Joyce, RM; Kraser, CN; Levine, J; McDermott, D; Regan, M; Tetrealt, JC; Uhl, L; Umiel, T | 1 |
| Benike, CJ; Caspar, CB; Czerwinsk, DK; Davis, TA; Engleman, EG; Hsu, FJ; Levy, R; Liles, TM; Taidi, B; van Beckhoven, A | 1 |
| Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C | 1 |
| Kobayashi, K; Matano, S; Minouchi, K; Ohta, H; Sanada, T; Sugimoto, T | 1 |
| Akiba, M; Bessho, M; Hirashima, K; Itoh, K; Itoh, Y; Kashimura, T; Kawai, N; Kishimoto, K; Matsuda, A; Murohashi, I; Sakata, T; Suzuki, T; Takahashi, T; Tominaga, K; Wakao, D; Yagasaki, F; Yoshida, K | 1 |
| Chabner, BA; Frankel, S; Grossbard, ML; Gutierrez, M; Jaffe, E; O'Connor, P; Wilson, WH | 1 |
| Agbalika, F; Boulanger, E; Daniel, MT; Grollet, L; Maarek, O; Molina, JM; Oksenhendler, E; Sigaux, F | 1 |
| Balis, F; Chabner, BA; Cheson, BD; Cole, D; Drbohlav, N; Grossbard, ML; Gutierrez, M; Harris, N; Jaffe, ES; Janik, J; Little, RF; Longo, DL; Pearson, D; Pittaluga, S; Raffeld, M; Staudt, L; Steinberg, SM; Wilson, WH; Wittes, R | 1 |
| Barbarano, L; Cairoli, R; Gargantini, L; Grillo, G; Marenco, P; Morra, E; Nosari, AM; Tedeschi, A; Tresoldi, E | 1 |
| Armata, J; Balcerska, A; Bogusławska-Jaworska, J; Bubala, H; Dluzniewska, A; Gacka, M; Jaworski, W; Jeleń, M; Kazanowska, B; Kowalczyk, J; Kołecki, P; Kurylak, A; Matysiak, M; Ploszyńska, A; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Sopylo, B; Stańczak, E; Stefaniak, MJ; Stefańska, K; Wróbel, G; Wysocki, M | 1 |
| Moskowitz, C | 1 |
| Ansoborlo, S; Babin-Boilletot, A; Baruchel, A; Pacquement, H; Patte, C; Plouvier, E; Sakiroglu, C | 1 |
| Fuse, Y; Katayama, Y; Kitamura, H; Kugai, N; Matsuura, Y; Motoyoshi, K; Nagata, N; Ohkawa, H; Wada, S | 1 |
| Fujita, T; Ito, M; Matsui, T; Nakao, Y; Natazuka, T; Sugimoto, T | 1 |
| Itatani, H; Itoh, H; Takatera, H; Tsujimura, T; Utsunomiya, M | 1 |
| Horie, H; Kinugawa, N; Kudoh, F; Miyamoto, S; Okimoto, Y; Oto, S | 1 |
7 review(s) available for etoposide and B-Cell Lymphoma
| Article | Year |
|---|---|
Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Methylprednisolone; Middle Aged; Prednisone; Proto-Oncogene Proteins c-myc; Radiotherapy; Rituximab; Translocation, Genetic; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2013 |
[Therapy-related acute myeloid leukemia following double autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Monocytic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary | 2002 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Erythema Induratum; Erythema Nodosum; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraneoplastic Syndromes; Prednisolone; Prednisone; Pregnancy; Procarbazine; Remission Induction; Vincristine | 2003 |
Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 8; Caspase 9; Caspase Inhibitors; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Models, Biological; Risk; Signal Transduction; Treatment Outcome | 2005 |
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Europe; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Multicenter Studies as Topic; Multiple Myeloma; National Institutes of Health (U.S.); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Pyrazines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; United States; Vinblastine; Vincristine | 2006 |
Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; CD40 Antigens; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Germinal Center; Humans; Immunoglobulin G; Integrin alpha4beta1; Integrins; Interleukin-4; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Mice; Neoplasm Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Interleukin-4; Receptors, Lymphocyte Homing; Tumor Cells, Cultured; Vascular Cell Adhesion Molecule-1 | 1999 |
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Chromosome Aberrations; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Drug Therapy, Combination; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunophenotyping; Interferon-alpha; Karyotyping; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prednisone; Prognosis; Remission Induction; Survival Analysis; Vincristine; Vindesine; Viral Load | 2001 |
60 trial(s) available for etoposide and B-Cell Lymphoma
| Article | Year |
|---|---|
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Transplantation, Autologous | 2021 |
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Etoposide; Female; Follow-Up Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Intention to Treat Analysis; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Progression-Free Survival; Rituximab; Safety; Topoisomerase II Inhibitors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2021 |
Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Models, Biological; Positron-Emission Tomography; Predictive Value of Tests; Survival Rate; Tomography, X-Ray Computed; Vincristine | 2018 |
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Recurrence; Survival Analysis; Treatment Failure; Young Adult | 2013 |
A prospective study of mediastinal gray-zone lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2014 |
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Humans; Immunotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lymphoma, B-Cell; Maintenance Chemotherapy; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Typhlitis; Vincristine | 2014 |
Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Rituximab; Salvage Therapy; Treatment Outcome | 2014 |
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Patient Selection; Prospective Studies; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Young Adult | 2015 |
[Clinical Efficacy Comparison between CHOPE Regimen alone and It Combined with Thalidomide for Relapsed and Refractory Non-Hodgkin's Lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lactate Dehydrogenases; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Prednisone; Survival Rate; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine | 2016 |
Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prospective Studies; Rituximab; Young Adult | 2009 |
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult | 2009 |
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Young Adult | 2009 |
Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Male; Middle Aged; Secondary Prevention; Transplantation Conditioning; Transplantation, Autologous | 2010 |
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2010 |
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Survival Analysis; Vincristine; Vindesine; Young Adult | 2010 |
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Prednisolone; Prednisone; Proportional Hazards Models; Prospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2011 |
Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Myeloablative Agonists; Prospective Studies; Radioimmunotherapy; Recurrence; Rituximab; Salvage Therapy; Stem Cell Transplantation | 2011 |
A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Prospective Studies; Quality of Life; Rituximab; Survival Rate; Transplantation Conditioning; Vidarabine | 2011 |
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Rituximab; Vincristine; Young Adult | 2012 |
Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Male; Mesna; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2002 |
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Mitoxantrone; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2003 |
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Recombinant Proteins; Survival Rate; Vincristine | 2003 |
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2004 |
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neutropenia; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous | 2004 |
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Factor Analysis, Statistical; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, T-Cell; Middle Aged; Prednisone; Prognosis; Recombinant Proteins; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2004 |
Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2004 |
Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Treatment Outcome; Venezuela; Vincristine | 2004 |
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infections; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Male; Middle Aged; Opportunistic Infections; Remission Induction; Rituximab; Survival Analysis | 2005 |
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Etoposide; Female; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Poly(ADP-ribose) Polymerases; Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Treatment Outcome; X-Linked Inhibitor of Apoptosis Protein | 2005 |
Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Radiotherapy Dosage; Recurrence; Survival Rate | 2005 |
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2005 |
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 2005 |
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Rate; Vincristine | 2005 |
Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cytarabine; Developing Countries; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Stem Cell Transplantation; Transplantation, Autologous | 2006 |
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2006 |
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2006 |
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Rituximab; Survival Analysis; Transplantation, Autologous; Vincristine | 2006 |
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Quality of Life; Survival Rate; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 2007 |
[Results of the SHOP LNHB98 (LMB89) trial in pediatric patients with B-cell non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Prednisone; Prospective Studies; Vincristine | 2007 |
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome | 2007 |
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2008 |
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Immunotherapy; Lymphoma, B-Cell; Middle Aged; Rituximab; Salvage Therapy; Stem Cell Transplantation | 2008 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
[Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Treatment Outcome | 1994 |
Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 1996 |
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Vincristine | 1998 |
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Iodine Radioisotopes; Lymphoma, B-Cell; Middle Aged; Neoplasm Staging; Radioimmunotherapy; Recurrence; Survival Rate; Tissue Distribution; Transplantation, Autologous | 2000 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Rate; Vincristine | 2001 |
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Lymphoma, B-Cell; Male; Middle Aged; Mitoxantrone; Recombinant Proteins; Remission Induction; Rituximab; Transplantation, Autologous | 2001 |
Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Antibodies, Anti-Idiotypic; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dendritic Cells; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hemocyanins; Humans; Ifosfamide; Immunity, Cellular; Immunoglobulin Idiotypes; Lymphocyte Activation; Lymphoma, B-Cell; Male; Polysorbates; Receptors, Antigen, B-Cell; Safety; Squalene; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vaccination; Whole-Body Irradiation | 2001 |
Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Time Factors; Vincristine | 2002 |
The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Middle Aged; Prednisone; Remission Induction; Rituximab; Vincristine | 2002 |
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Monitoring; Etoposide; Female; Humans; Longitudinal Studies; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Platelet Count; Prednisone; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2002 |
137 other study(ies) available for etoposide and B-Cell Lymphoma
| Article | Year |
|---|---|
Identification of a glutathione peroxidase inhibitor that reverses resistance to anticancer drugs in human B-cell lymphoma cell lines.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Catalytic Domain; Cattle; Cell Line, Tumor; Crystallography, X-Ray; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutathione Peroxidase; Humans; Hydrazones; Inhibitory Concentration 50; Lymphoma, B-Cell; Molecular Structure | 2012 |
Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Vincristine | 2021 |
Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Vincristine | 2022 |
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine | 2022 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Rituximab; Thalidomide; Treatment Outcome | 2023 |
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Treatment Outcome; Vincristine | 2023 |
Bilateral Endobronchial Masses and Severe Hypoxemic Respiratory Failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Hypoxia; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Respiratory Insufficiency; Tomography, X-Ray Computed; Vincristine | 2019 |
Venetoclax Boosts Benefits of R-EPOCH in Aggressive B-Cell Lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Sulfonamides; Vincristine | 2020 |
Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Incidence; Lung Diseases, Interstitial; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Risk Factors; Rituximab; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine; Young Adult | 2020 |
Safety and financial analysis of outpatient dose-adjusted EPOCH for B-cell lymphoma at a tertiary comprehensive cancer center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Outpatients; Prednisone; Retrospective Studies; Vincristine | 2021 |
Evaluating the incidence of chemotherapy-induced nausea and vomiting in patients with B-cell lymphoma receiving dose-adjusted EPOCH and rituximab.
Topics: Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Incidence; Lymphoma, B-Cell; Male; Middle Aged; Nausea; Prednisone; Retrospective Studies; Rituximab; Vincristine; Vomiting | 2022 |
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Rituximab; Treatment Outcome | 2021 |
DA-EPOCH-R therapy for high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in a patient with renal dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Biopsy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Rearrangement; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Kidney Diseases; Kidney Function Tests; Lymphoma, B-Cell; Male; Neoplasm Grading; Neoplasm Staging; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2021 |
Image Gallery: Immunocompromised patient presenting with inguinal rash: a case of Scedosporium apiospermum.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Dermatomycoses; Dexamethasone; Drug Eruptions; Etoposide; Exanthema; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Lymphoma, B-Cell; Male; Opportunistic Infections; Scedosporium; Voriconazole | 2017 |
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Recurrence; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2017 |
Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Treatment Outcome; Vincristine | 2017 |
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Humans; Lymphoma, B-Cell; Male; Mitoxantrone; Prednisone; Rituximab; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 2018 |
R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Management; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prednisone; Recurrence; Retrospective Studies; Rituximab; Treatment Failure; Treatment Outcome; Vincristine; Young Adult | 2018 |
What is the standard of care for primary mediastinal B cell lymphoma; R-CHOP or DA-EPOCH-R? - Response to Melani et al.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Prednisone; Standard of Care; Vincristine | 2019 |
What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Prednisone; Standard of Care; Vincristine | 2019 |
Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 3; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression Profiling; Gene Order; Genes, myc; Humans; In Situ Hybridization, Fluorescence; Lymphoma, B-Cell; MDS1 and EVI1 Complex Locus Protein; Middle Aged; Neoplasm Grading; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Remission Induction; Sequence Analysis, RNA; Translocation, Genetic; Treatment Outcome; Vincristine | 2018 |
R-ICE Chemotherapy with or without Autologous Transplantation for Elderly Patients with Relapsed or Refractory Aggressive B-Cell Lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2018 |
Ofatumumab in diffuse large B cell lymphoma?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male | 2013 |
Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Vincristine; Young Adult | 2014 |
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; L-Lactate Dehydrogenase; Leucovorin; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 2014 |
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Lymphoma, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Podophyllotoxin; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
High concentrations of glucose suppress etoposide-induced cell death of B-cell lymphoma through BCL-6.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carrier Proteins; Caspases; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Glucose; Humans; Lymphoma, B-Cell; Proto-Oncogene Proteins c-bcl-6 | 2014 |
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lymphoma, B-Cell; Prednisone; Recurrence; Remission Induction; Risk; Rituximab; Salvage Therapy; Vidarabine; Vincristine; Virus Activation | 2014 |
[Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytogenetic Analysis; DNA-Binding Proteins; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Male; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Translocation, Genetic; Vincristine | 2015 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Logistic Models; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Multivariate Analysis; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 2016 |
A patient with cancer and nail pigmentation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma, B-Cell; Nail Diseases; Nails; Pigmentation Disorders; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2016 |
Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fertility; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Menstruation; Middle Aged; Prednisone; Pregnancy; Pregnancy Outcome; Rituximab; Vincristine; Young Adult | 2016 |
MYC/BCL2 double-hit lymphoma/leukemia mimicking acute leukemia at initial presentation.
Topics: Abnormal Karyotype; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autografts; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Flow Cytometry; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Leukemia; Leukocytosis; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisone; Proto-Oncogene Proteins c-bcl-2; Rituximab; Vincristine | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
Circulating lymphoma cells of double-hit lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Gastrointestinal Hemorrhage; Humans; Lymphoma, B-Cell; Male; Pancytopenia; Prednisone; Treatment Outcome; Vincristine; Weight Loss | 2016 |
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Polyethylene Glycols; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2017 |
[A case of unclassified B-cell lymphosarcoma].
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Diagnosis, Differential; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Middle Aged; Remission Induction; Tomography, X-Ray Computed | 2008 |
Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. Case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachial Plexus Neuropathies; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Peripheral Nervous System Neoplasms; Prednisone; Proto-Oncogene Proteins c-bcl-6; Rituximab; Vincristine | 2009 |
Chemotherapy as treatment for colo-colonic intussusception associated with acquired immune deficiency syndrome-related lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Intussusception; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
Efficacy and safety of modified rituximab-ESHAP therapy for relapsed/refractory B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Rituximab | 2010 |
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cisplatin; Colony-Stimulating Factors; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Remission Induction; Rituximab | 2010 |
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Cyclophosphamide; DNA Damage; Drug Resistance, Neoplasm; Etoposide; Lymphoma, B-Cell; Membrane Proteins; Mice; Mice, Knockout; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Proteins | 2010 |
Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrosourea Compounds; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Young Adult | 2011 |
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2011 |
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2010 |
Treatment of progression during reductive prophase for paediatric primary mediastinal B-cell lymphoma using dose-adjusted EPOCH chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Prednisone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
[Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2011 |
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome | 2011 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Grading; Neoplasm Invasiveness; Prednisolone; Prednisone; Rituximab; Societies, Medical; Vincristine; Young Adult | 2012 |
Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Irinotecan; Lymphoma, B-Cell; Nuclear Proteins; Organoplatinum Compounds; Oxaliplatin; Polycomb Repressive Complex 1; Proto-Oncogene Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survivin; Tumor Cells, Cultured | 2012 |
Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with ⁹⁰Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Melphalan; Radioimmunotherapy; Treatment Outcome; Yttrium Radioisotopes | 2012 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine | 2012 |
[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult | 2012 |
Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response.
Topics: Animals; Antimetabolites, Antineoplastic; Blotting, Western; Calreticulin; Cell Death; Cell Line, Tumor; Deoxyglucose; Drug Therapy, Combination; Etoposide; Glycolysis; Kaplan-Meier Estimate; Lymphocyte Activation; Lymphoma, B-Cell; Mice; Mice, Inbred C57BL; Mice, Transgenic; RNA Interference; T-Lymphocytes | 2012 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bicarbonates; Bleomycin; Ciprofloxacin; Crystallization; Cyclophosphamide; Cytarabine; Diarrhea; Doxorubicin; Drug Eruptions; Drug Interactions; Etoposide; Female; Fluid Therapy; Fungemia; Humans; Hydrogen-Ion Concentration; Ifosfamide; Lymphoma, B-Cell; Mediastinal Neoplasms; Metabolic Clearance Rate; Methotrexate; Mucositis; Pancytopenia; Prednisone; Solubility; Urine; Vindesine | 2013 |
Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Exocrine Pancreatic Insufficiency; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Pancreatic Neoplasms; Pancreatitis; Remission Induction; Tomography, X-Ray Computed | 2002 |
Lymphoma in an ileostomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ileal Neoplasms; Ileostomy; Lymphoma, B-Cell; Male; Prednisolone; Vincristine | 2002 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Drug Resistance, Viral; Etoposide; Female; HIV Reverse Transcriptase; Humans; Immunohistochemistry; Leukocyte Common Antigens; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mutation; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; T-Lymphocytes; Treatment Outcome; Vincristine; Viral Load | 2003 |
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prognosis; Sclerosis; Treatment Outcome | 2003 |
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mitoguazone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Vinblastine; Vincristine | 2003 |
BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Doxycycline; Etoposide; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Humans; Leupeptins; Lymphoma, B-Cell; Membrane Potentials; Mitochondria; Multienzyme Complexes; Mutation; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Reactive Oxygen Species; Transcription Factors; Tumor Cells, Cultured | 2003 |
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Prognosis; Treatment Outcome | 2003 |
[Focal concentrations in the hepatic CT in superior vena cava thrombosis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Lymphoma, B-Cell; Prednisolone; Rituximab; Superior Vena Cava Syndrome; Time Factors; Tomography, X-Ray Computed; Vincristine | 2003 |
Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspase 9; Caspases; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Viral Proteins | 2004 |
Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 8; Combined Modality Therapy; Dexamethasone; DNA-Binding Proteins; Etoposide; Genes, bcl-2; Genes, myc; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Radiotherapy, Adjuvant; Remission Induction; Transcription Factors; Translocation, Genetic | 2004 |
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Eye Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Middle Aged; Prognosis; Recurrence; Thiotepa | 2004 |
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Interferon-gamma; Interleukin-4; Intracellular Fluid; Lymphocyte Count; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells; Vincristine | 2004 |
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Salvage Therapy; Treatment Outcome | 2004 |
[Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Survival Rate; Vincristine; Vindesine | 2004 |
[Treatment of primary mediastinal large B-cell lymphomas].
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance.
Topics: Apoptosis; Apoptotic Protease-Activating Factor 1; Caspases; Cell Line, Tumor; Cell Membrane; Cytochromes c; Cytosol; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, B-Cell; Mitochondria; Protein Transport; Proteins | 2005 |
[Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Humans; Ileal Neoplasms; Liver Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Remission Induction; Stomach Neoplasms | 2005 |
Procaspase-2S inhibits procaspase-3 processing and activation, preventing ROCK-1-mediated apoptotic blebbing and body formation in human B lymphoma Namalwa cells.
Topics: Apoptosis; Blotting, Western; Caspase 2; Caspase 3; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Membrane; Cell-Free System; DNA; DNA Fragmentation; Enzyme Activation; Etoposide; Humans; Immunoprecipitation; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Lymphoma, B-Cell; Monocytes; Protein Serine-Threonine Kinases; Recombinant Proteins; rho-Associated Kinases; Time Factors; Transfection; U937 Cells | 2005 |
Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous | 2005 |
[Mediastinal large B-cell lymphoma with symptomatic superior vena cava syndrome in a patient with bichorial twin pregnancy in the 26th week of gestation: peri-and postpartal management -- a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Lymphoma, B-Cell; Magnetic Resonance Imaging; Parity; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Superior Vena Cava Syndrome; Treatment Outcome; Vincristine | 2005 |
A Case of Burkitt's Lymphoma Involving Both Breasts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine | 2005 |
p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposide.
Topics: CDC2 Protein Kinase; Etoposide; G2 Phase; Humans; Lymphoma, B-Cell; p38 Mitogen-Activated Protein Kinases | 2005 |
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |
[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Thrombocytopenia; Vinblastine | 2005 |
[Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Transplantation, Autologous; Treatment Outcome | 2005 |
Bronchial infiltration with diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bronchial Neoplasms; Carboplatin; DNA Primers; Etoposide; Gene Rearrangement; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Lymphoma, B-Cell; Male; Middle Aged; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
[A case of secondary malignant lymphoma of the urinary bladder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Middle Aged; Mitoxantrone; Prednisone; Urinary Bladder Neoplasms; Vincristine | 2006 |
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Recombinant Proteins; Recurrence; Retrospective Studies; Rituximab; Vincristine | 2006 |
False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; False Positive Reactions; Humans; Ifosfamide; Laparoscopy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Spleen; Splenectomy; Tomography, X-Ray Computed; Unnecessary Procedures; Vincristine | 2006 |
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine | 2006 |
Results of CHOP chemotherapy for diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Prednisone; Proportional Hazards Models; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2006 |
[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2006 |
Therapy for older patients with diffuse large cell lymphoma: targeting the treatment to the patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Autologous | 2007 |
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italian
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Rituximab; Transplantation, Autologous; Treatment Outcome | 2007 |
Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea.
Topics: Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chlamydophila psittaci; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; DNA, Bacterial; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Eye Neoplasms; Follow-Up Studies; Humans; Korea; Lymphoma, B-Cell; Polymerase Chain Reaction; Prednisone; Psittacosis; Retrospective Studies; Secondary Prevention; Sequence Analysis, DNA; Time Factors; Vincristine | 2007 |
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2007 |
[Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Rituximab; Vincristine | 2007 |
Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Transplantation, Homologous | 2007 |
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Biphenyl Compounds; Blotting, Western; Doxorubicin; Etoposide; Humans; Immunoblotting; Immunoprecipitation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Membrane Proteins; Nitrophenols; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Cells, Cultured; Vincristine | 2007 |
[Case of malignant lymphoma associated with rheumatoid arthritis].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Humans; Lymph Nodes; Lymphoma, B-Cell; Mediastinum; Methotrexate; Prednisolone; Remission Induction; Rituximab; Tomography, X-Ray Computed; Vincristine | 2008 |
Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Prostatectomy; Prostatic Neoplasms; Rituximab; Survival | 2008 |
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Humans; Lymph Nodes; Lymphoma, B-Cell; Male; Middle Aged; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Tomography, X-Ray Computed; Vincristine | 1994 |
Myelin basic protein in the cerebrospinal fluid of patients with brain tumors.
Topics: Adult; Aged; Astrocytoma; Biomarkers, Tumor; Brain Damage, Chronic; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Intra-Arterial; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Myelin Basic Protein; Treatment Outcome | 1994 |
Remission of recurrent primary intracranial malignant lymphoma after high-dose intra-arterial corticosteroid administration and intra-arterial chemotherapy--case report.
Topics: Adrenal Cortex Hormones; Adult; Brain; Brain Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Humans; Infusions, Intra-Arterial; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous | 1994 |
The management of primary mediastinal B-cell lymphoma with sclerosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Prednisone; Sclerosis; Vincristine | 1994 |
Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukapheresis; Lymphocyte Count; Lymphocyte Subsets; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Mesna; Middle Aged; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Treatment Outcome; Vincristine | 1995 |
[Successful oral administration of etoposide therapy for refractory malignant lymphoma treated with frequent combination chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Salvage Therapy; Vincristine | 1993 |
Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58).
Topics: Alkaloids; Antibodies, Anti-Idiotypic; Apoptosis; Dexamethasone; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Humans; Immunoglobulin M; Lymphoma, B-Cell; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1995 |
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone | 1997 |
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 1998 |
Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Transformation, Viral; Chickens; Dactinomycin; DNA Damage; DNA Replication; DNA, Ribosomal; Etoposide; Genes, myc; Kinetics; Lymphoma, B-Cell; Lymphoma, T-Cell; Topoisomerase I Inhibitors; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
BCNU is a caspase-mediated inhibitor of drug-induced apoptosis.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Carmustine; Caspase 3; Caspases; Cysteine Endopeptidases; Dexamethasone; Etoposide; Humans; Lymphoma, B-Cell; Tumor Cells, Cultured | 1998 |
High-dose chemotherapy and autologous transplantation in lymphomatous polyposis in second remission: three case reports and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Polyps; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Prednisone; Transplantation, Autologous; Vincristine | 1998 |
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumonia; Prednisolone; Pulmonary Fibrosis; Vascular Neoplasms; Vincristine | 1998 |
[A case of primary malignant lymphoma of the bladder].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Remission Induction; Urinary Bladder Neoplasms; Vincristine | 1998 |
Cytotoxicity of 2-chlorodeoxadenosine (cladribine, 2-cdA) in combination with other chemotherapy drugs against two lymphoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chlorambucil; Cisplatin; Cladribine; Drug Screening Assays, Antitumor; Etoposide; Humans; Lymphoma, B-Cell; Paclitaxel; Tumor Cells, Cultured | 1999 |
T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease.
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Immunophenotyping; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Neoplasm Staging; Recurrence; T-Lymphocytes; Vincristine | 1999 |
Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrosobenzamide.
Topics: Animals; Benzamides; Caspase 3; Caspase Inhibitors; Cell Survival; Cells, Cultured; Dexamethasone; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Enzyme Precursors; Etoposide; Flow Cytometry; Humans; Kinetics; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Nitroso Compounds; Recombinant Proteins; T-Lymphocytes; Tumor Cells, Cultured | 1999 |
Modulation of apoptosis and enhancement of chemosensitivity by decreasing cellular thiols in a mouse B-cell lymphoma cell line that overexpresses bcl-2.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Lymphoma, B-Cell; Mice; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
Oxidative burst measurement in patients treated with cytostatics: influence of G-CSF and role as a prognostic factor.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Escherichia coli; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Prognosis; Respiratory Burst; Tetradecanoylphorbol Acetate | 2000 |
Diffuse bone increase uptake of gallium-67 related to cyclophosphamide and recombinant human granulocyte-colony stimulating factor (rHuG-CSF) administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Gallium Radioisotopes; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Radionuclide Imaging; Recombinant Proteins; Tissue Distribution | 2000 |
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Immunohistochemistry; Lomustine; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prednimustine; Prednisone; Regression Analysis; Survival Analysis; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine | 2000 |
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Piperazines; Recurrence; Topoisomerase II Inhibitors | 2000 |
Complete remission of generalized relapsed extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type of the gastrointestinal tract after high-dose chemotherapy and autologous peripheral stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Melphalan; Middle Aged; Remission Induction; Transplantation, Autologous | 2000 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, B-Cell; Palliative Care; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Treatment Outcome; Vincristine | 2001 |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine | 2001 |
Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatitis B, Chronic; Humans; Interferon-alpha; Liver Function Tests; Lymphoma, B-Cell; Male; Nitrosourea Compounds; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Transplantation, Autologous; Vincristine; Viremia; Virus Activation | 2001 |
Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Prognosis; Risk Factors; Sclerosis; Thorax; Transplantation, Autologous; Vincristine | 2002 |
[Abdominal presentation of B-cell non-Hodgkin's lymphoma (B-NHL) - surgical treatment and its results. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Laparotomy; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Prednisone; Risk Factors; Time Factors; Treatment Outcome; Vincristine | 2000 |
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Prognosis; Randomized Controlled Trials as Topic; Risk; Treatment Outcome | 2002 |
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; France; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vincristine | 2002 |
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cisplatin; Creatinine; Cyclic AMP; Cytarabine; Etoposide; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Osteocalcin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Prednisolone; Procarbazine; Proteins | 1992 |
Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cefoperazone; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1992 |
Bilateral primary non-Hodgkin's lymphoma of the adrenal glands with adrenal insufficiency: a case report.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Remission Induction; Vincristine | 1992 |
Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bloom Syndrome; Child; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Etoposide; Female; Genetic Predisposition to Disease; Humans; Hydrocortisone; Lymphoma, B-Cell; Methotrexate; Pharyngeal Neoplasms; Prednisolone; Prognosis; Remission Induction | 1992 |